**Core Concept**
Neo-adjuvant chemotherapy refers to the administration of chemotherapy before the primary treatment (surgery or radiation) to reduce the size of a tumor and make it easier to remove. This approach is used in various types of cancer to improve surgical outcomes and decrease the risk of recurrence.

**Why the Correct Answer is Right**
Neo-adjuvant chemotherapy is typically used in cancers where a significant reduction in tumor size can improve surgical outcomes. In the case of brain tumors, the blood-brain barrier limits the effectiveness of chemotherapy, and surgical resection is often the primary treatment. Additionally, the primary treatment for brain tumors is usually radiation therapy or surgery, rather than chemotherapy.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, but in general, neo-adjuvant chemotherapy is not typically used in cancers where the primary treatment is radiation therapy alone, such as certain types of skin cancers.
**Option B:** This option is not provided, but in general, neo-adjuvant chemotherapy may be used in cancers where a significant reduction in tumor size can improve surgical outcomes, such as breast cancer or soft tissue sarcomas.
**Option C:** This option is not provided, but in general, neo-adjuvant chemotherapy may be used in cancers where a significant reduction in tumor size can improve surgical outcomes, such as esophageal cancer or pancreatic cancer.
**Option D:** This option is not provided, but in general, neo-adjuvant chemotherapy is not typically used in cancers where the primary treatment is surgery alone, such as certain types of thyroid cancer.

**Clinical Pearl / High-Yield Fact**
The use of neo-adjuvant chemotherapy should be individualized based on the type and stage of cancer, as well as the patient's overall health and treatment goals. It is essential to weigh the potential benefits of neo-adjuvant chemotherapy against the potential risks and side effects.

**Correct Answer:** D